Immunogenicity and Bioassay Summit
Archived Content

Past Attendee Quotes from Previous Summits:

“I have attended a number of immunogenicity/bioassay-related conferences, and I found CHI’s to be the most informative for me.”
Chief Scientific Officer, Selecta Biosciences 

“That was a great conference and wonderful to meet so many great new colleagues.”
Scientist, Bioanalytical Sciences, Genentech, Inc. 

“Congratulations again! It was one of the best-attended immunogenicity & bioassay meetings that I have been to. That certainly attests to your skill in keeping participants, speakers, and sponsors happy."
Professor, Research, University of Rhode Island 

“Nice meeting; good mix of assays, technologies and experimental science.”
Senior Scientist, Biomarin 

“It was a pleasure being at the conference: very high quality!”
Senior Expert, Immunogenicity and Bioanalysis, TNA, a Netherlands Applied Research Center 

“Great event to interact with KOIs from industry and FDA to educate and re-educate yourself on aspects of immunogenicity of biologicals in the preclinical to clinical phases of drug development”
Director, Complex Generics, Momenta Pharmaceuticals 

“Very informative and thought provoking meeting; high quality presentations; As a newcomer to the field, I found this conference to be an excellent resource to help me better develop strategies for advancing novel protein therapeutics.”
Team Lead, Immunology Translational Medicine, Janssen R&D, LLC 

“Well organized conference with great scientific presentations and meeting content.”
Senior Principal Scientist, Drug Safety R&D, Pfizer, Inc. 

“Program and participants, first class.”
Associate Director, Novo Nordisk 

“Break-out interaction with FDA experts was very valuable.”
Associate Director, Alexion Pharmaceuticals Inc. 

“Congratulations on a very well put together conference.”
Assistant Vice President, Pfizer 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  


2015 Brochure Cover  


IMN Podcast iconReducing and Monitoring Bioassay Variability

2013 Speaker: Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefenseDivision, Emergent BioSolutions